Pediatrix Medical Group, Inc. (MD) Stock
3 members of Congress disclosed 4 trades in MD since 2015: 2 purchases and 2 sales, most recently Donna Shalala (sale, Oct 15, 2019). 5 of the hedge funds AlphaScala tracks reported MD in 13F filings for the quarter ended Sep 30, 2026; the largest reported position is D.E. Shaw's at $40.86M.
Which members of Congress traded Pediatrix Medical Group, Inc. (MD)?
Most recent: Donna Shalala (sale, Oct 15, 2019); records start May 27, 2015.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Donna Shalala D-FL · House | 2019-10-15 | sale | $50k – $100k |
| Lamar Smith R-TX · House | 2016-02-22 | purchase | $1k – $15k |
| Lamar Smith R-TX · House | 2016-01-25 | purchase | $1k – $15k |
| Tom MacArthur R-NJ · House | 2015-05-27 | sale | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026.
See all MD political trades →Which hedge funds own MD?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| D.E. Shaw David Shaw | 1.61M | $40.86M | -6% |
| Renaissance Technologies Jim Simons (founder) | 1.29M | $32.61M | -16% |
| Hussman Investment Trust John Hussman | 105K | $2.70M | +67% |
| Millennium Management Israel Englander | 55K | $1.40M | NEW |
| Marshall Wace | 34K | $872.1K | NEW |
13F holdings as of Sep 30, 2026
Explore all tracked funds →MD price chart
Powered by TradingViewWhat does Pediatrix Medical Group, Inc. do?
Pediatrix Medical Group, Inc. operates as a leading provider of physician services within the broader healthcare sector, focusing specifically on neonatal, maternal-fetal, pediatric cardiology, and other related areas. The primary purpose of Pediatrix Medical Group is to ensure specialized and high-quality healthcare for women and children, prioritizing the critical care aspects that are often underserved. Notable for their comprehensive service offerings, Pediatrix plays an essential role in hospital-based management, offering an array of services including clinical staffing, administrative support, and healthcare management solutions. The company's impact on the healthcare industry is significant, as it supports both hospitals and clinics across the United States in delivering superior patient care. As a specialized provider, Pediatrix Medical Group holds a crucial position in addressing the healthcare needs of vulnerable populations, contributing to improved outcomes in neonatal and pediatric care sectors. This strengthens their market significance as they help meet the growing demand for specialized medical services in a dynamic healthcare environment.